Bioequivalence testing for combination products like fixed-dose combos, topical creams, and inhalers faces major scientific and regulatory hurdles. Learn why generics for these drugs take years to approve - and what’s being done to fix it.
Explains when doctors prescribe brand-name drugs instead of generics. Covers medical necessity, cost differences, and patient considerations. Learn how to discuss options with your healthcare provider.
Learn how the FDA ensures generic drugs meet the same safety, quality, and strength standards as brand-name medications through bioequivalence testing, strict manufacturing rules, and rigorous inspections.